Clinical Trial Update: Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Kidney Removal [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pre-operative use of sorafenib in patients with metastatic renal cell carcinoma undergoing nephrectomy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Nexavar (Sorafenib)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Renal Cell Carcinoma, Metastatic Disease | Phase 2 | Status: COMPLETED